From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease.
- DOI
- 10.1007/s40263-026-01333-5
- Published
- 2026 Sep 15
- Container
- CNS drugs
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40263-026-01333-5,
title = {From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease.},
author = {Perneczky R and Jessen F and Grimmer T and Levin J and Hufnagel A and Flöel A and Peters O and Froelich L and Hofmann A and Working Group New Therapies, Monitoring of the German Network Memory Clinics},
year = {2026},
journal = {CNS drugs},
doi = {10.1007/s40263-026-01333-5},
url = {https://doi.org/10.1007/s40263-026-01333-5}
}RIS
TY - JOUR TI - From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease. AU - Perneczky R AU - Jessen F AU - Grimmer T AU - Levin J AU - Hufnagel A AU - Flöel A AU - Peters O AU - Froelich L AU - Hofmann A AU - Working Group New Therapies, Monitoring of the German Network Memory Clinics PY - 2026 JO - CNS drugs DO - 10.1007/s40263-026-01333-5 UR - https://doi.org/10.1007/s40263-026-01333-5 ER -
APA
R, P., F, J., T, G., J, L., A, H., A, F., O, P., L, F., A, H., & Clinics, W. G. N. T. M. O. T. G. N. M. (2026). From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's Disease.. CNS drugs. https://doi.org/10.1007/s40263-026-01333-5
Source records
- pubmed · retrieved 2026-09-25T03:34:12.093Z